Evidence map›Paper›PMID 38586723›Full record

ArticleCureus2024

Primary Effusion Lymphoma Secondary to Human Herpesvirus 8 (HHV-8) Infection in an Immunocompetent Host: A Case Report.

Sagar Pandey, Ernestine Faye S Tan, Myo Myint Tun, Amulya Bellamkonda, Shwe Yee Htet, Kalendra Kunwar, Madhumati Kalavar

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sagar PandeyInternal Medicine, One Brooklyn Health/Interfaith Medical Center, Brooklyn, USA.
Ernestine Faye S TanInternal Medicine, One Brooklyn Health/Interfaith Medical Center, Brooklyn, USA.
Myo Myint TunInternal Medicine, NewYork-Presbyterian Westchester Hospital, Bronxville, USA.
Amulya BellamkondaInternal Medicine, One Brooklyn Health/Interfaith Medical Center, Brooklyn, USA.
Shwe Yee HtetInternal Medicine, One Brooklyn Health/Interfaith Medical Center, Brooklyn, USA.
Kalendra KunwarInternal Medicine, One Brooklyn Health/Interfaith Medical Center, Brooklyn, USA.
Madhumati KalavarHematology and Oncology, One Brooklyn Health/Interfaith Medical Center, Brooklyn, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary effusion lymphoma (PEL) is a rare, aggressive, mature type of B-cell lymphoma that usually causes malignant, lymphomatous effusions in the absence of a solid mass. This is commonly seen in immunosuppressed individuals such as those with underlying malignancies, human immunodeficiency virus infection (HIV), cirrhosis, and a history of solid organ transplantation who are infected with human herpesvirus 8 (HHV-8). Clinical presentation varies depending on the extent of disease like shortness of breath, abdominal distention, and typical B symptoms like weight loss, fever, and night sweats. Morphological and immunohistochemical analysis of pleural fluid is required for diagnosis of PEL. Recent case studies are increasingly being reported with cases of PEL presenting in immunocompetent individuals infected with HHV-8. We present a case of PEL in an immunocompetent host and highlight its presentation, diagnosis, and management approaches. Due to the well-known association of PEL with immunocompromised status, the diagnosis is often overlooked in immunocompetent individuals. This case would further highlight the increasing association and the need for clinical vigilance in diagnosing PEL in immunocompetent patients.

Indexed as

hhv 8immunocompetent patientslymphomanon-hodgins lymphomaprimary effusion lymphoma

Identifiers

PMID38586723
PMCPMC10999059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.